Benchmark Electronics, Inc. — FY2022 Form 10-K
Reporting period: Fiscal year ended December 31, 2022. This is an annual filing; the supplied text does not provide standalone fourth-quarter results. Unless noted, amounts are in U.S. dollars.
Business context
Benchmark provides electronics manufacturing, precision technology, design and engineering, and technology solutions to OEMs in aerospace and defense, medical, industrial, semiconductor capital equipment, advanced computing, and next-generation communications markets. It reports geographically across the Americas, Asia, and Europe. Its strategy centers on complex, higher-value products and integrated design-to-production services.
Financial results and liquidity
| Metric | FY2022 | FY2021 |
|---|---|---|
| Revenue | $2,886.3 million | $2,255.3 million |
| Gross profit / margin | $255.2 million / 8.8% | $205.9 million / 9.1% |
| Operating income / margin | $90.1 million / 3.1% | $53.1 million / 2.4% |
| Net income | $68.2 million | $35.8 million |
| Diluted EPS | $1.91 | $0.99 |
| Cash from operating activities | $(177.5) million | $(2.6) million |
| Capital expenditures | $43.4 million | $38.8 million |
- Revenue rose 28%; operating income rose 70%, and net income rose 91%. Gross margin declined 0.3 percentage points, which management attributed primarily to higher supply-chain premiums.
- Operating cash outflow reflected substantial working-capital investment, including increases of $206.2 million in inventory and $136.5 million in accounts receivable, partly offset by $79.8 million of higher customer advances.
- Cash and restricted cash were $207.4 million at year-end, down from $271.7 million. Working capital was approximately $0.9 billion, versus $0.7 billion a year earlier.
- Gross principal debt was $326.3 million at year-end: $131.3 million term loan and $195.0 million revolving-credit borrowings. The company reported $251.1 million of additional revolver availability, subject to covenants, and compliance with its financial covenants.
- Cash dividends paid were $23.2 million; share repurchases totaled $9.4 million. The quarterly dividend was $0.165 per share. Management said available cash, operating cash flows, and revolver availability should meet liquidity needs for the next 12 months.
Material changes versus FY2021
- Growth was broad-based: sales increased 39% in Industrials, 28% in Medical, 31% in Semi-Cap, 56% in Advanced Computing, and 36% in Next Generation Communications. A&D sales fell 9% amid market constraints.
- International operations generated 61% of sales, up from 55%. Sales to the ten largest customers rose to 52% of total sales from 47%; Applied Materials accounted for 15%, compared with 16%.
- SG&A increased to $150.2 million from $136.7 million, reflecting higher variable compensation, IT investment, and medical expenses. Interest expense rose to $12.9 million from $8.5 million, partly due to higher rates and borrowings.
- The company used $177.5 million in operating cash, compared with $2.6 million in FY2021. Inventory increased to $727.7 million from $523.2 million, and accounts receivable increased to $492.0 million from $355.9 million.
Outlook, risks, contingencies, and unusual items
- No specific revenue or earnings guidance is provided in the supplied filing text. Management expects FY2023 capital expenditures of approximately $60–$70 million, principally for machinery and equipment to support anticipated growth.
- Management reported continued component shortages, extended lead times, supplier allocations, labor constraints, inflation, and shipment timing disruptions. These conditions constrained the ability to meet customer demand and contributed to operating inefficiencies and inventory growth.
- Customer concentration is material: the ten largest customers represented 52% of revenue, and one customer represented 17% of gross accounts receivable at year-end. Most customers do not commit to firm production schedules more than one quarter ahead.
- FY2022 restructuring and other costs were $8.6 million on the income statement. The company separately described $5.7 million of restructuring charges, including site closures and workforce reductions; it also recorded a $2.0 million loss on equipment held for sale, a $2.4 million gain on the Angleton building sale, and agreed to $3.3 million in legal settlements.
- Tax incentives reduced FY2022 tax expense by approximately $9.0 million. The China incentive expires in 2023; the Malaysia tax-holiday extension application had not received an official response. Management also disclosed $48.3 million of remaining U.S. transition-tax liability, payable through 2025.
- The company cited risks from COVID-related disruption, supply-chain and labor conditions, customer demand shifts, geopolitical and trade developments, foreign exchange, variable interest rates, cyberattacks, regulatory compliance, and natural disasters. Adequate flood insurance for Thailand facilities was not available on cost-effective terms.
- The 10-K reports that the financial statements received an unqualified audit opinion and that internal control over financial reporting was effective at December 31, 2022. The auditor identified evaluation of income tax expense as a critical audit matter.
Important facts for investors to verify
- Whether inventory and receivables convert to cash as supply constraints ease, and how customer advances and contract assets develop.
- Whether gross margins recover from supply-chain premiums and new-program ramp costs, while the company executes planned capacity investment.
- Customer concentration, particularly Applied Materials exposure, and the effect of any order reductions, delays, or payment difficulties.
- Debt, borrowing availability, variable-rate exposure, covenant headroom, and the company’s capacity to sustain dividends and buybacks.
- Status of the Malaysia tax-holiday extension and the scheduled expiration of the China incentive, along with related tax assumptions and liabilities.